Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Solution vs Lactated Ringer's for Post-ERCP Pancreatitis
NCT05832047Phase 4Completed
- Start
- Jun 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of plasmalyte in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP). Started Jun 2023; status: completed.
02
Drugs
plasmalyte
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT05832047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05832047.